Acute energy restriction triggers Wallerian degeneration in mouse

Experimental Neurology

Volumn 212, Issue 1, 2008, Pages 166-178

  Alvarez, Susana ^a   Moldovan, Mihai ^a   Krarup, Christian ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Nerve activity; Persistent conduction block

Indexed keywords

1 [2 (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; 2,4 DINITROPHENOL; AMMONIUM DERIVATIVE; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CELL ENERGY; CONTROLLED STUDY; ELECTRIC ACTIVITY; ELECTRODE; ENERGY RESTRICTION; FEMALE; HYPOTHESIS; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE BLOCK; NERVE CONDUCTION; NERVE DEGENERATION; NERVE FIBER; NERVE POTENTIAL; NERVE STIMULATION; NEUROTOXICITY; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; SCIATIC NERVE; SURGICAL WOUND; TIBIAL NERVE;

2,4-DINITROPHENOL; ANIMALS; AXONS; CELL RESPIRATION; ENERGY METABOLISM; FEMALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEURAL CONDUCTION; NEURONS, AFFERENT; NITRIC OXIDE; PERIPHERAL NERVES; SCIATIC NERVE; UNCOUPLING AGENTS; WALLERIAN DEGENERATION;

EID: 44649096898     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.03.022     Document Type: Article

References (57)

1. Bechtold D.A., and Smith K.J. Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J. Neurol. Sci. 233 (2005) 27-35
2. Bechtold D.A., Kapoor R., and Smith K.J. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann. Neurol. 55 (2004) 607-616
3. Bechtold D.A., Yue X., Evans R.M., Davies M., Gregson N.A., and Smith K.J. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 128 (2005) 18-28
4. Bechtold D.A., Miller S.J., Dawson A.C., Sun Y., Kapoor R., Berry D., and Smith K.J. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J. Neurol. 253 (2006) 1542-1551
5. Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., and Coleman M.P. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC. Neurosci. 6 (2005) 6
6. Bolanos J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., and Heales S.J. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68 (1997) 2227-2240
7. Brookes P.S., Bolanos J.P., and Heales S.J. The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett. 446 (1999) 261-263
8. Brown G.C., Bolanos J.P., Heales S.J., and Clark J.B. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193 (1995) 201-204
9. Buki A., Okonkwo D.O., Wang K.K., and Povlishock J.T. Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20 (2000) 2825-2834
10. Chen C., and Schofield G.G. Nitric oxide donors enhanced Ca2+ currents and blocked noradrenaline-induced Ca2+ current inhibition in rat sympathetic neurons. J. Physiol 482 Pt 3 (1995) 521-531
11. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 17 (2000) 843-855
12. Fujimura H., Lacroix C., and Said G. Vulnerability of nerve fibres to ischaemia A quantitative light and electron microscope study. Brain 114 Pt 4 (1991) 1929-1942
13. Garthwaite G., Goodwin D.A., Batchelor A.M., Leeming K., and Garthwaite J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 109 (2002) 145-155
14. George E.B., Glass J.D., and Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15 (1995) 6445-6452
15. Gilliatt R.W., and Hjorth R.J. Nerve conduction during Wallerian degeneration in the baloon. J. Neurol Neurosurg. Psychiatry 35 (1972) 335-341
16. Gitler D., and Spira M.E. Real time imaging of calcium-induced localized proteolytic activity after axotomy and its relation to growth cone formation. Neuron 20 (1998) 1123-1135
17. Hammarstrom A.K., and Gage P.W. Nitric oxide increases persistent sodium current in rat hippocampal neurons. J. Physiol. 520 Pt 2 (1999) 451-461
18. Hirooka K., Kourennyi D.E., and Barnes S. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. J. Neurophysiol 83 (2000) 198-206
19. Hodgkin A.L., and Keynes R.D. Active transport of cations in giant axons from sepia and loligo. J. Physiol 128 (1955) 28-60
20. Hooper D.C., Ohnishi S.T., Kean R., Numagami Y., Dietzschold B., and Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. U. S A. 92 (1995) 5312-5316
21. Hrabie J.A., Klose J.R., Wink D.A., and Keefer L.K. New Nitric Oxide-Releasing Zwitterions Derived from Polyamines. J. Org. Chem. 58 (1993) 1472-1476
22. Ikegami K., and Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 122 (2003) 617-626
23. Jin Y., McEwen M.L., Nottingham S.A., Maragos W.F., Dragicevic N.B., Sullivan P.G., and Springer J.E. The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. J. Neurotrauma 21 (2004) 1396-1404
24. Kakizawa H., Matsui F., Tokita Y., Hirano K., Ida M., Nakanishi K., Watanabe M., Sato Y., Okumura A., Kojima S., and Oohira A. Neuroprotective effect of nipradilol, an NO donor, on hypoxic-ischemic brain injury of neonatal rats. Early Hum. Dev. 83 8 Aug (2007) 535-540
25. Kapoor R., Davies M., and Smith K.J. Temporary axonal conduction block and axonal loss in inflammatory neurological disease A potential role for nitric oxide?. Ann. N. Y. Acad. Sci. 893 (1999) 304-308
26. Kapoor R., Davies M., Blaker P.A., Hall S.M., and Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 53 (2003) 174-180
27. Kim Y.M., Talanian R.V., and Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272 (1997) 31138-31148
28. Korde A.S., Pettigrew L.C., Craddock S.D., and Maragos W.F. The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. J. Neurochem. 94 (2005) 1676-1684
29. Korde A.S., Sullivan P.G., and Maragos W.F. The uncoupling agent 2,4-dinitrophenol improves mitochondrial homeostasis following striatal quinolinic acid injections. J. Neurotrauma 22 (2005) 1142-1149
30. Lehning E.J., Doshi R., Isaksson N., Stys P.K., and LoPachin Jr. R.M. Mechanisms of injury-induced calcium entry into peripheral nerve myelinated axons: role of reverse sodium-calcium exchange. J. Neurochem. 66 (1996) 493-500
31. Li Z., Chapleau M.W., Bates J.N., Bielefeldt K., Lee H.C., and Abboud F.M. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 20 (1998) 1039-1049
32. Loomis W.F., and Lipmann F. Reversible inhibition of the coupling between phosphorylation and oxidation. J. Biol. Chem. 173 (1948) 807-808
33. Lubinska L. Early course of Wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res. 130 (1977) 47-63
34. Lunn E.R., Perry V.H., Brown M.C., Rosen H., and Gordon S. Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur. J. Neurosci. 1 (1989) 27-33
35. Lyon M.F., Ogunkolade B.W., Brown M.C., Atherton D.J., and Perry V.H. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9717-9720
36. Maragos W.F., Rockich K.T., Dean J.J., and Young K.L. Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions. Brain Res. 966 (2003) 312-316
37. Miledi R., and Slater C.R. On the degeneration of rat neuromuscular junctions after nerve section. J. Physiol 207 (1970) 507-528
38. Moldovan M., and Krarup C. Evaluation of Na(+)/K(+) pump function following repetitive activity in mouse peripheral nerve. J. Neurosci. Methods 155 Sep. 15 (2006) 161-171
39. Okamoto M., and Riker Jr. W.F. Motor nerve terminals as the site of initial functional changes after denervation. J. Gen. Physiol. 53 (1969) 70-80
40. Prochazka A., and Gorassini M. Models of ensemble firing of muscle spindle afferents recorded during normal locomotion in cats. J. Physiol 507 Pt 1 (1998) 277-291
41. Redford E.J., Kapoor R., and Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120 Pt 12 (1997) 2149-2157
42. Regnault C., Roch-Arveiller M., Florentin I., Giroud J.P., Postaire E., and Delaforge M. Kinetic evaluation of nitric oxide production in pleural exudate after induction of two inflammatory reactions in the rat. Inflammation 20 (1996) 613-622
43. Renganathan M., Cummins T.R., and Waxman S.G. Nitric oxide blocks fast, slow, and persistent Na+ channels in C-type DRG neurons by S-nitrosylation. J. Neurophysiol. 87 (2002) 761-775
44. Schlaepfer W.W. Calcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve. Brain Res. 69 (1974) 203-215
45. Schlaepfer W.W. Structural alterations of peripheral nerve induced by the calcium ionophore A23187. Brain Res. 136 (1977) 1-9
46. Schmidt K., Desch W., Klatt P., Kukovetz W.R., and Mayer B. Release of nitric oxide from donors with known half-life: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedeberg's Arch. Pharmacol. 355 (1997) 457-462
47. Shrager P., Custer A.W., Kazarinova K., Rasband M.N., and Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J. Neurophysiol. 79 (1998) 529-536
48. Sievers C., Platt N., Perry V.H., Coleman M.P., and Conforti L. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci. Res. 46 (2003) 161-169
49. Skou J.C. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta 23 (1957) 394-401
50. Smith K.J., Kapoor R., Hall S.M., and Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 49 (2001) 470-476
51. Stewart V.C., and Heales S.J. Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic. Biol. Med. 34 (2003) 287-303
52. Stys P.K., Waxman S.G., and Ransom B.R. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann. Neurol. 30 (1991) 375-380
53. Stys P.K., Waxman S.G., and Ransom B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J. Neurosci. 12 (1992) 430-439
54. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations on the alterations produced thereby in the structure of their primitive fibers. Philos. Trans. R. Soc. Lond B Biol. Sci. 140 (1850) 423-429
55. Waxman S.G., Black J.A., Ransom B.R., and Stys P.K. Anoxic injury of rat optic nerve: ultrastructural evidence for coupling between Na+ influx and Ca(2+)-mediated injury in myelinated CNS axons. Brain Res. 644 (1994) 197-204
56. Calibration by decomposition of SNAP using Cu(II) as a catalyst. ISO-NO Mark II Instruction Manual (2002) 22-26
57. Zhang X.J., Cardosa L., Broderick M., Fein H., and Davies I.R. Novel calibration method for nitric oxide microsensors by stoichiometrical generation of nitric oxide from SNAP. Electroanalysis 12 (2000) 425-428